A photo of Parinda Mehta.

Member, Division of Bone Marrow Transplantation and Immune Deficiency

Professor, UC Department of Pediatrics



Board Certified

About Me

Academic Affiliation

Professor, UC Department of Pediatrics


Cancer and Blood Diseases, Bone Marrow Transplantation BMT, Fanconi Anemia, Leukemia

My Locations

My Education

BA: Graduated from Parle College, Mumbai, India, 1988.

MD: G.S. Medical College and K.E.M Hospital, Mumbai, India, 1993.

Residency: Upstate Medical University (UMU) - State University of New York (SUNY), Syracuse, NY, 2002.

Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2005.

Certification: Board Certification, Pediatrics, 2002; Board Certification, Pediatric Hematology Oncology, License, State of Ohio.

My Publications

Selected Publication

Busulfan Pharmacokinetics and Precision Dosing: Are Patients with Fanconi Anemia Different?. Mehta, PA; Emoto, C; Fukuda, T; Seyboth, B; Teusink-Cross, A; Davies, SM; Wilhelm, J; Fuller, K; Vinks, AA; Boulad, F. Biology of Blood and Marrow Transplantation. 2019; 25:2416-2421.

Unique Challenges of Hematopoietic Cell Transplantation in Adolescent and Young Adults with Hematologic Malignancies. Mehta, PA; Rotz, SJ; Majhail, NS. Biology of Blood and Marrow Transplantation. 2018; 24:e11-e19.

Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. Dvorak, CC; Satwani, P; Stieglitz, E; Cairo, MS; Dang, H; Pei, Q; Gao, Y; Wall, D; Mazor, T; Olshen, AB; et al. Pediatric Blood and Cancer. 2018; 65:e27034-e27034.

Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study. Chandra, S; Fukuda, T; Mizuno, K; Davies, SM; Teusink-Cross, A; Tarin, R; Marsh, RA; Vinks, AA; Mehta, PA. Journal of Antimicrobial Chemotherapy. 2018; 73:1651-1658.

Subsequent neoplasms and late mortality in children undergoing allogeneic transplantation for nonmalignant diseases. Kahn, JM; Brazauskas, R; Tecca, HR; Bo-Subait, S; Buchbinder, D; Battiwala, M; Flowers, ME D; Savani, BN; Phelan, R; Broglie, L; et al. Blood Advances. 2020; 4:2084-2094.

Population pharmacokinetic modelling of busulfan and the influence of body composition in paediatric Fanconi anaemia patients. van Hoogdalem, MW; Emoto, C; Fukuda, T; Mizuno, T; Mehta, PA; Vinks, AA. British Journal of Clinical Pharmacology. 2020; 86:933-943.

Association of clinical severity with FANCB variant type in Fanconi anemia. Jung, M; Ramanagoudr-Bhojappa, R; van Twest, S; Rosti, RO; Murphy, V; Tan, W; Donovan, FX; Lach, FP; Kimble, DC; Jiang, CS; et al. Blood. 2020; 135:1588-1602.

Chromosome fragility in the buccal epithelium in patients with Fanconi anemia. Jose Ramirez, M; Minguillon, J; Loveless, S; Lake, K; Carrasco, E; Stjepanovic, N; Balmana, J; Catala, A; Mehta, PA; Surralles, J. Cancer Letters. 2020; 472:1-7.

Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation. Saad, A; Lamb, L; Wang, T; Hemmer, MT; Spellman, S; Couriel, D; Alousi, A; Pidala, J; Abdel-Azim, H; Agrawall, V; et al. Biology of Blood and Marrow Transplantation. 2019; 25:1875-1883.

Outcomes after Second Hematopoietic Cell Transplantation in Children and Young Adults with Relapsed Acute Leukemia. Lund, TC; Ahn, KW; Tecca, HR; Hilgers, MV; Abdel-Azim, H; Abrahams, A; Angel Diaz, M; Badawy, SM; Broglie, L; Brown, V; et al. Biology of Blood and Marrow Transplantation. 2019; 25:301-306.